Tag: casts

Categories
Entertainment

See the Shameless Forged’s Goodbye Posts For Sequence Finale

See the Shameless Cast's Goodbye Posts For Series Finale

It’s the end of an era. April 11th is Showtime Shameless ends after 11 seasons and a lot of drama within the Gallagher family. The cast have practically grown up together over the past 10 years, and their goodbye messages show how much the series meant to them. Actors Emma Kenney, Cameron Monaghan, Steve Howey, William H. Macy and others recognized all of the work that went on their show on Instagram with behind-the-scenes photos and wrap party pictures.

Monaghan summed it up best when he wrote, “It’s the end of the day. You don’t have to go home, but you can’t stay here. Thank you for coming with us.” Take a look at the cast’s sentimental notes. We’re already counting down the days before we can get the entire series back on Netflix.

Categories
World News

U.S. well being company casts doubt over AstraZeneca vaccine knowledge

U.S. health agency casts doubt over AstraZeneca vaccine data

A nurse makes syringes with the preparation of Astrazeneca in Axel Stelzner’s family doctor’s practice.

Hendrik Schmidt | Image alliance via Getty Images

LONDON – A US health agency on Tuesday expressed concern that AstraZeneca may have included out of date information from a clinical trial of its Covid-19 vaccine, which may cast doubt on the published efficacy results.

The Data Safety Monitoring Board “was concerned that AstraZeneca may have included out of date information from this study that may provide an incomplete view of the efficacy data,” the US National Institute of Allergy and Infectious Diseases said in a statement.

“We urge the company to work with the DSMB to review efficacy data and ensure that the most accurate and up-to-date efficacy data is released as soon as possible.”

The NIAID is led by the White House Chief Medical Officer, Dr. Anthony Fauci, directs and is part of the National Institutes of Health.

AstraZeneca did not immediately respond to a CNBC request for comment.

The statement comes just a day after the results of a large U.S. study showed that the coronavirus vaccine developed by AstraZeneca and Oxford University is 79% effective against symptomatic illness and 100% effective against serious illness and hospitalization.

Data from the late-stage human study was based on more than 32,000 volunteers at 88 trial centers in the United States, Peru, and Chile.

The results were welcomed as “surprisingly positive” and “good news for the global community”.

AstraZeneca said it plans to prepare the primary analysis, which will be submitted to the U.S. Food and Drug Administration for emergency approval before mid-April.

The Oxford AstraZeneca vaccine had been temporarily suspended in several countries after blood clots were reported in some people who had been vaccinated. However, AstraZeneca said Monday that the independent DSMB had not found an increased risk of blood clots.

Ruud Dobber, executive vice president of AstraZeneca’s biopharmaceuticals business, told CNBC’s “Squawk Box” Monday that it was “very gratifying to see that the Data Safety Monitoring Board, even with a magnifying glass, is not an imbalance between the vaccinated group and the vaccinated group the placebo group. “

“That gives us a lot of confidence,” he added.

Categories
Politics

Sen. Joe Manchin casts doubts on $2,000 stimulus checks

Sen. Joe Manchin casts doubts on $2,000 stimulus checks

Senator Joe Manchin, DW. Va., Visited in the Russell Building on Thursday, July 30, 2020.

Tom Williams | CQ Appeal, Inc. | Getty Images

Democratic Senator Joe Manchin signaled on Friday that he could speak out against direct payments of US $ 2,000, thereby jeopardizing one of his party’s priorities if it takes unified control of the White House and Congress.

The Washington Post initially quoted West Virginia lawmakers as saying they would “absolutely” disapprove of another coronavirus relief check on Americans. He later explained his comment in a tweet statement, saying, “When the next round of stimulus checks expires, they should be aimed at those who need them.”

Manchin, the most conservative Democrat in the Senate, questioned the cost of the proposal. The bipartisan Joint Tax Committee previously said an increase in payments in the State Aid Act passed last month from $ 600 to $ 2,000 would cost $ 463 billion.

His stance casts doubt on what kind of direct deposit plan could get through the Senate when the Democrats have a wafer-thin majority. The party will have control of a 50:50 chamber for the coming weeks following the January 20 inauguration and the swearing-in of Democratic-elected Senators Raphael Warnock and Jon Ossoff of Georgia.

Manchin’s comments appeared to be causing a temporary decline in major stock indices on Friday.

President-elect Joe Biden and Democratic Congress leaders have called for trillions of dollars more in pandemic rescue spending as Americans struggle to pay bills and rent during an ongoing virus outbreak. Biden called the $ 900 billion relief plan approved last month a “down payment.” The urge for more assistance comes when the Labor Department reported the US lost 140,000 jobs in December.

Biden, Warnock and Ossoff said the Democratic election in Georgia would mean the Senate could write $ 2,000 checks.

Republicans can ensure that most laws take 60 votes to pass. However, it is expected that Democrats will have three options to use the budget vote process, which will allow certain measures related to spending to be passed by majority vote.

Some people must not doom the passage of payments to failure. At least one Republican – Senator Josh Hawley of Missouri – backed $ 2,000 checks last month when President Donald Trump urged them. It is unclear whether or how the president’s departure or the pro-Trump mob attack on the Capitol this week will affect GOP payments-related policies.

The House passed a bill last month to increase the checks in the relief bill from $ 600 to $ 2,000. Individuals earning up to $ 75,000 in 2019 would receive the full amount and gradually expire until a cap of $ 115,000 is reached.

Subscribe to CNBC on YouTube.